UK's Arden Biotech, which was awarded £247,846 (US$350,559) as part of this UKRI funding initiative, is collaborating with Canada's TrustBIX Inc on a feed related project.
Arden has developed a novel bacteriophage cocktail, a feed supplement to:
combat clostridium perfringens
enhance gut health
reduce the risk of necrotic enteritis.
Through this collaborative 24-month industrial research project, Arden is seeking to extend the development of this technology to the Canadian poultry and other livestock sectors in partnership with TrustBIX.